Clinical Trial Update: Cardiac Stem/Progenitor Cell Infusion in Univentricular Physiology (APOLLON Trial) [Phase 3]

View source ↗

Summary

APOLLON is a Phase 3 trial evaluating infusion of cardiac stem/progenitor cells in patients with univentricular physiology, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoplastic Left Heart Syndrome
• Single Ventricle

Drugs mentioned

• Cardiac stem/progenitor cell infusion

Snippet

Sponsor: Metcela Inc. | Conditions: Hypoplastic Left Heart Syndrome, Single Ventricle | Phase 3 | Status: RECRUITING